The combination of 18 F-fluorodeoxyglucose and 18 F 9-fluoropropyl-(+)-dihydrotetrabenazine positron emission tomography for distinguishing between early-onset and late-onset idiopathic Parkinson disease and analyzing influencing factors.

MLA

Li, Shuang, et al. “The Combination of 18 F-Fluorodeoxyglucose and 18 F 9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography for Distinguishing between Early-Onset and Late-Onset Idiopathic Parkinson Disease and Analyzing Influencing Factors.” Quantitative Imaging in Medicine and Surgery, vol. 14, no. 10, Oct. 2024, pp. 7406–19. EBSCOhost, https://doi.org/10.21037/qims-24-804.

APA

Li, S., Lu, W., Yan, S., Song, T., Zhang, C., Yang, C., & Lu, J. (2024). The combination of 18 F-fluorodeoxyglucose and 18 F 9-fluoropropyl-(+)-dihydrotetrabenazine positron emission tomography for distinguishing between early-onset and late-onset idiopathic Parkinson disease and analyzing influencing factors. Quantitative Imaging in Medicine and Surgery, 14(10), 7406–7419. https://doi.org/10.21037/qims-24-804

Chicago

Li, Shuang, Weizhao Lu, Shaozhen Yan, Tianbin Song, Chun Zhang, Chang Yang, and Jie Lu. 2024. “The Combination of 18 F-Fluorodeoxyglucose and 18 F 9-Fluoropropyl-(+)-Dihydrotetrabenazine Positron Emission Tomography for Distinguishing between Early-Onset and Late-Onset Idiopathic Parkinson Disease and Analyzing Influencing Factors.” Quantitative Imaging in Medicine and Surgery 14 (10): 7406–19. doi:10.21037/qims-24-804.